These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28624143)

  • 1. A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b.
    Berg A; Berg T
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3349-3352. PubMed ID: 28624143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomolar inhibitors of the transcription factor STAT5b with high selectivity over STAT5a.
    Elumalai N; Berg A; Natarajan K; Scharow A; Berg T
    Angew Chem Int Ed Engl; 2015 Apr; 54(16):4758-63. PubMed ID: 25702814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrically Substituted m-Terphenyl Phosphates Inhibit the Transcription Factor STAT5a.
    Müller-Klieser D; Berg T
    Chembiochem; 2022 Feb; 23(4):e202100603. PubMed ID: 34905258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated Fragments.
    Natarajan K; Müller-Klieser D; Rubner S; Berg T
    Chemistry; 2020 Jan; 26(1):148-154. PubMed ID: 31503360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
    Kassack MU; Braun K; Ganso M; Ullmann H; Nickel P; Böing B; Müller G; Lambrecht G
    Eur J Med Chem; 2004 Apr; 39(4):345-57. PubMed ID: 15072843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel gankyrin binding scaffolds by high throughput virtual screening.
    Kanabar D; Kabir A; Chavan T; Kong J; Yoganathan S; Muth A
    Bioorg Med Chem Lett; 2021 Jul; 43():128043. PubMed ID: 33865970
    [No Abstract]   [Full Text] [Related]  

  • 7. Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist.
    Rettinger J; Braun K; Hochmann H; Kassack MU; Ullmann H; Nickel P; Schmalzing G; Lambrecht G
    Neuropharmacology; 2005 Mar; 48(3):461-8. PubMed ID: 15721178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin analogues with a 2-phenylbenzimidazole moiety as partial structure; potential anti HIV- and angiostatic drugs, 2: Sulfanilic acid-, benzenedisulfonic acid-, and naphthalenetrisulfonic acid analogues.
    Kreimeyer A; Müller G; Kassack M; Nickel P; Gagliardi AR
    Arch Pharm (Weinheim); 1998 Mar; 331(3):97-103. PubMed ID: 9557135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization.
    Müller J; Schust J; Berg T
    Anal Biochem; 2008 Apr; 375(2):249-54. PubMed ID: 18258175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the reversal effect of NF449 on neuromuscular blockade induced by d-tubocurarine.
    Su TR; Hung YS; Huang SS; Su HH; Su CC; Hsiao G; Chen YH; Lin MJ
    Life Sci; 2011 Jun; 88(23-24):1039-46. PubMed ID: 21453711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity.
    Page BD; Khoury H; Laister RC; Fletcher S; Vellozo M; Manzoli A; Yue P; Turkson J; Minden MD; Gunning PT
    J Med Chem; 2012 Feb; 55(3):1047-55. PubMed ID: 22148584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suramin analogues as subtype-selective G protein inhibitors.
    Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
    Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP Inhibits the Transcription Factor STAT5b.
    Berg A; Sperl B; Berg T
    Chembiochem; 2019 Sep; 20(17):2227-2231. PubMed ID: 30985989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate.
    Nishimura Y; McLaughlin NP; Pan J; Goldstein S; Hafenstein S; Shimizu H; Winkler JD; Bergelson JM
    PLoS Pathog; 2015 Oct; 11(10):e1005184. PubMed ID: 26430888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10.
    Paulson CN; John K; Baxley RM; Kurniawan F; Orellana K; Francis R; Sobeck A; Eichman BF; Chazin WJ; Aihara H; Georg GI; Hawkinson JE; Bielinsky AK
    Open Biol; 2019 Aug; 9(8):190117. PubMed ID: 31409229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput screen reveals new small-molecule activators and inhibitors of pantothenate kinases.
    Sharma LK; Leonardi R; Lin W; Boyd VA; Goktug A; Shelat AA; Chen T; Jackowski S; Rock CO
    J Med Chem; 2015 Feb; 58(3):1563-8. PubMed ID: 25569308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of receptor/G protein coupling by suramin analogues.
    Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
    Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors.
    Nagao S; Yamane Y; Funasaka S; Tanaka K; Miyazaki K; Kotake Y; Kamata J; Watanabe-Miyano S; Toyama O; Ozawa Y; Mizui Y; Okamoto K; Ito D
    Bioorg Med Chem; 2014 Oct; 22(19):5513-29. PubMed ID: 25139751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel quinolizidine derivate IMB-HDC inhibits STAT5a phosphorylation at 694 and 780 and promotes DNA breakage and cell apoptosis via blocking STAT5a nuclear translocation.
    Zhao WL; Xing Y; Ye C; Qiu YH; Li Y; Liu XJ; Wang MY; Bi CW; Song DQ; Shao RG
    Acta Pharmacol Sin; 2020 May; 41(5):686-697. PubMed ID: 31932645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.